Related Experiment Video
Updated: Mar 20, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.4K
Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away
Alex Lee1, Paul Huang1, Ronald P DeMatteo1
1From the Department of Medical Oncology, Royal Marsden Hospital London, United Kingdom; Institute of Cancer Research, London, United Kingdom; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; Fred Hutchinson Cancer Research Center, Division of Oncology, University of Washington, Seattle, WA.
Summary
Immunotherapies show promise for advanced soft tissue sarcoma by harnessing immune responses. Manipulating the tumor microenvironment and using vaccines can direct immune cells to fight cancer.
Area of Science:
- Oncology
- Immunology
Background:
- Advanced soft tissue sarcoma lacks effective immunologic therapies despite progress in other cancers.
- Spontaneous immune responses against sarcomas are observed and can be induced.
Purpose of the Study:
- To review current clinical and preclinical data on immunotherapy for soft tissue sarcoma.
- To explore strategies for manipulating the sarcoma immune microenvironment.
- To identify opportunities for integrating sarcomas into broader cancer immunotherapy advancements.
Main Methods:
- Review of recent clinical and preclinical studies on sarcoma immunology.
- Analysis of immune responses in soft tissue sarcoma.
- Evaluation of immunotherapeutic approaches including vaccines and T-cell engineering.
Main Results:
- Immune responses against sarcomas can be spontaneous or provoked.
- Modulating the sarcoma immune microenvironment may eradicate disease.
- Immunotherapies can sensitize sarcomas to other treatments.
Conclusions:
- Immunotherapy holds significant potential for treating advanced soft tissue sarcoma.
- Targeting the sarcoma immune microenvironment and utilizing T-cell therapies are promising strategies.
- Sarcomas can benefit from the ongoing revolution in cancer immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K